Home / Pharmaceutical / The Pharmaceutical Market: Turkey

The Pharmaceutical Market: Turkey

Published: Nov 2014 | No Of Pages: 126 | Published By: Espicom

Product Synopsis

OVERVIEW OF THE PHARMACEUTICAL MARKET IN TURKEY
 
The cooling economic environment and the weakening lira has moderated optimistic forecasts on the Turkish pharmaceutical market, especially as the government is the single largest reimburser of pharmaceuticals, covering 80-85% of total drug expenditure through various insurance and immunisation schemes. Price cutting and public discount decrees announced in November 2011 continue to affect the pharmaceutical market in 2012, as highlighted by the decrease in pharmaceutical spending in the first half of this year.
 
Headline Expenditure Projections
  • Pharmaceuticals: TRY17.21bn (US$10.24bn) in 2011 to TRY16.35bn (US$9.03bn) in 2012; -5.0% in local currency terms and -11.8% in US dollar terms. Localcurrencyforecastdowngradedfrom Q412on account of H112 data.
  • Healthcare: TRY83.59bn (US$49.75bn) in 2011 to TRY92.02bn (US$50.84bn) in 2012; +10.1% in local currency terms and +2.2%in US dollar terms. Localcurrency forecastslightly increased fromQ412due to increased healthcare investment.
  • Medical devices: TRY4.33bn (US$2.58bn) in 2011 to TRY4.78bn (US$2.64bn) in 2012; +10.3% in local currency terms and +2.4% in US dollar terms. Localcurrencyforecastbroadly unchangedfrom Q412.
Competitive Landscape
 
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI Industry View7
SWOT9
Political11
Economic13
Business Environment14
Industry Forecast15
Pharmaceutical Market Forecast15
 
Table: Pharmaceutical Sales, Historical Data And Forecasts (Turkey 2010-2018)17
 
Healthcare Market Forecast18
 
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2010-2018)19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2010-2018)19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2010-2018)20
 
Prescription Drug Market Forecast20
 
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Turkey 2010-2018)22
 
Patented Drug Market Forecast22
 
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Turkey 2010-2018)23
 
Generic Drug Market Forecast24
 
Table: Generics Drug Market Indicators, Historical Data And Forecasts (Turkey 2010-2018)25
 
OTC Medicine Market Forecast26
 
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Turkey 
2010-2018)27
 
Pharmaceutical Trade Forecast28
 
Table: Pharmaceutical Trade Data And Forecasts (Turkey 2012-2018)29
Table: Pharmaceutical Trade Data And Forecasts local currency (Turkey 2012-2018)29
 
Key Risks To BMI's Forecast Scenario29
Macroeconomic Forecasts31
 
Table: Turkey - GDP By Expenditure38
 
Industry Risk Reward Ratings39
Central And Eastern Europe Risk/Reward Ratings39
Turkey Risk/Reward Ratings46
Rewards46
Risks47
Market Overview48
Industry Trends And Developments50
Epidemiology50
Healthcare Sector51
Healthcare Insurance52
Healthcare Infrastructure52
Healthcare Financing54
Research & Development55
Clinical Trials57
Regulatory Development59
Intellectual Property Regime60
Market Access Issues63
Pricing Regime64
 
Table: Turkish Pharmaceutical Pricing Decrees66
 
Reimbursement Regime67
 
Table: Pharmacist Discount Related To Annual Sales Revenue (VAT Excluded)68
 
Competitive Landscape69
Pharmaceutical Sector69
Domestic Industry70
Foreign Industry71
Company Activity72
Wholesale73
Pharmaceutical Retail Sector74
Company Profile76
Abdi -brahim76
Eczaciba-i Healthcare80
Sanovel Pharmaceuticals84
EastPharma (Deva)87
Mustafa Nevzat Ilac Sanayi (MN) Pharmaceuticals91
Novartis95
Pfizer97
Sanofi100
GlaxoSmithKline103
Roche106
AstraZeneca109
Bayer111
Merck & Co113
Demographic Forecast115
Demographic Outlook115
 
Table: Turkey's Population By Age Group, 1990-2020 ('000)116
Table: Turkey's Population By Age Group, 1990-2020 (% of population)117
Table: Turkey's Key Population Ratios, 1990-2020118
Table: Turkey's Rural And Urban Population, 1990-2020118
 
Glossary119
Methodology121
Pharmaceutical Expenditure Forecast Model121
Healthcare Expenditure Forecast Model121
Notes On Methodology122
Risk/Reward Ratings Methodology123
Ratings Overview124
 
Table: Pharmaceutical Risk/Reward Ratings Indicators124
 
Indicator Weightings125
Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +